Live Broadcast to Explore a Treatment Option for EGFR Exon20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer

Article

In an upcoming live broadcast, Dr. Mark Socinski and Dr. Erminia Massarelli will discuss EGFR Exon20 insertion-positive non-small cell lung cancer and take a deeper look at current guideline-recommended testing. They will also talk about the safety and efficacy of a new option in patients previously treated with platinum-based chemotherapy. Additionally, they will discuss the implications of the data through a live question and answer session.

To obtain expert perspective and learn about how these results may affect your patients and your practice, watch the live broadcast on November 16th at 7PM ET or 9PM ET or November 17th at 12PM ET. To register for the event, visit https://studio.mjhassoc.com/reach/takedaonclivebroadcast.

USO-NON-0332 10/21

Related Videos
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Edgardo S. Santos Castillero, MD, FACP
Joshua K. Sabari, MD
Coral Olazagasti, MD
Samuel Rosner, MD
Balazs Halmos, MD
Wally Curran, MD